News

The deal will see the two parties establish a global strategic collaboration to jointly develop next generation immunotherapies to treat cancer and auto-immune diseases. NantWorks, through a subsidiary,

NEOD001 targets the circulating soluble amyloid and deposited insoluble amyloid that accumulates in both the AL and AA forms of amyloidosis. According to the company, this is the

The new regulatory submission follows the Japanese approval of dolutegravir as Tivicay tablets 50mg in March 2014. In the approved regions, the single-pill dolutegravir-based regimen is called as

The drug is used for growth deficiency in adults and children as well as for growth failure in babies born small who fail to catch up growth by

The Phase III LUX-Breast 1 trial compared afatinib plus vinorelbine (experimental arm) with trastuzumab plus vinorelbine in patients with HER2-positive metastatic breast cancer after failure of prior trastuzumab-based

GARDASIL 9 is also approved for use in boys 9 to 15 years of age for the prevention of anal cancer caused by HPV types 16, 18, 31,

The approved label changes are limited to revisions pertaining to the product’s storage, instructions of use and use in special populations, and do not impact its indication. "We’re

The new dosage strengths are 8.6 mg/2.1 mg and 11.4 mg/2.9 mg buprenorphine/naloxone CIII sublingual tablets. The 8.6 mg/2.1 mg dosage strength is expected to be launched early

This is Mettrum’s second license under the MMPR. The license authorizes Agripharm to grow 9,000 marihuana plants at its facility located on 80 acres of appropriately-zoned land in